ARTICLES BY THIS AUTHOR
- 12/15/2020
NCPA outlines ideal provisions for forthcoming relief package
The National Community Pharmacists Association is urging Congressional leaders to extend the Paycheck Protection Program to help independent pharmacies who have been on the front lines serving patients amid the pandemic. - 12/15/2020
Schnucks teammates awarded gift cards to local restaurants
Schnucks teammates will receive a $15 gift card to a restaurant within five miles of their work location in order for the retailer to support local business while recognizing its employees. - 12/15/2020
iA announces Reseller Agreement with BD
iA’s Symphony Software platform will integrate the BD Rowa Pouch Packaging Solution, expanding iA’s solutions offering to include compliance packaging. - 12/14/2020
Moderna’s COVID-19 vaccine likely to clear last hurdle within the week
Moderna’s COVID-19 vaccine could be administered to the public as early as Dec. 21, if it wins emergency use authorization from the Food and Drug Administration. - 12/14/2020
Hy-Vee offering extra bonus for pharmacists, techs performing rapid antigen COVID-19 tests
Hy-Vee's full-time pharmacists who administer rapid antigen COVID-19 tests each will receive a $500 bonus, while part-time pharmacists and technicians each will receive a $250 bonus. - 12/14/2020
Upsher-Smith launches generic Rozerem
Ramelteon had a market value of approximately $26 million for the 12 months ended October 2020, according to IQVIA. - 12/14/2020
1health, STChealth intro patient engagement COVID-19 vaccination solution
STChealth and 1health are rolling out an open platform that will provide pharmacists, physicians and patients with an easy to navigate tool to capture vaccination results, reported side effects and immunization reminders. - 12/14/2020
MSN Labs obtains FDA OK for two generics
Novadoz has commenced shipping generic Fareston, and will begin shipping generic Amicar shortly. - 12/14/2020
Cipla reaches patent litigation settlement with Celgene on generic Revlimid
Celgene has agreed to provide Cipla with a license to its patents required to manufacture and sell certain volume-limited amounts of generic lenalidomide in the United States beginning on a confidential date some time after March 2022. - 12/14/2020
If you've got it, flaunt it: Rite Aid’s Store of the Future puts pharmacists front and center
Rite Aid’s new RxEvolution strategy for success is its Store of the Future, in which the intent is bringing pharmacists out of their customary place in the back of the store and prominently placing them front and center.